Stocks · News reference

CVRx shares are trading lower after Cantor Fitzgerald lowered its price target on the stock from $13 to $5.

Aug 17, 2026, 7:09 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 21, 2026, 8:13 PMSEC EDGAR
8-K filing — CVRx, Inc. (CVRX)
Filed: 2026-09-21 AccNo: 0001104659-26-109304 Size: 247 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
CVRX
BenzingaSep 21, 2026, 8:08 PMBenzinga Newsdesk
CVRx Appoints John Landry CFO, Effective Oct. 12, Succeeding Jared Oasheim
CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular
CVRX
BenzingaAug 24, 2026, 6:12 PMBenzinga Newsdesk
CVRx shares are trading higher after the company announced that Devoted Health has issued a Medicare Advantage coverage policy for Barostim therapy.
CVRX
BenzingaAug 24, 2026, 12:35 PMBenzinga Newsdesk
CVRx Shareholder Urges Board To Launch Sale Process To Unlock Barostim’s Strategic Value
CVRX